DEF 14A: OptiNose Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

Sentiment:

Proxy Statement


OptiNose is holding a special meeting to seek stockholder approval for a reverse stock split to increase its stock price and maintain its Nasdaq listing.

Summary

  • OptiNose is proposing a reverse stock split of its common stock at a ratio between 1-for-10 and 1-for-100, with the exact ratio to be determined by the Board of Directors.
  • The primary reason for the reverse stock split is to increase the company's stock price to meet Nasdaq's minimum bid price requirement of $1.00 per share.
  • The company received a notice from Nasdaq on October 16, 2024, stating that its stock price had fallen below the minimum requirement.
  • OptiNose has until April 14, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.
  • If the company fails to regain compliance, it could face delisting from the Nasdaq Global Select Market, which could have significant adverse consequences.
  • The reverse stock split will not change the number of authorized shares of common or preferred stock, nor will it change the par value of the common stock.
  • The reverse stock split will affect all stockholders uniformly, and each stockholder will hold the same percentage of common stock immediately following the split, except for adjustments due to fractional shares.
  • Stockholders will not receive fractional shares; instead, they will receive cash equal to the value of the fractional share based on the closing price on the effective date of the split.
  • The Board may choose not to implement the reverse stock split even if approved by stockholders, and the authority to do so expires one year after stockholder approval.
  • As of November 25, 2024, there were 150,829,507 shares of common stock issued and outstanding.

Sentiment

Score: 5

Explanation: The document is neutral in tone, presenting the facts of the reverse stock split proposal and its potential benefits and risks. While the company is facing a delisting threat, the proposed action is a standard response, and the document does not express undue optimism or pessimism.

Positives

  • The reverse stock split is intended to increase the stock price, which could help maintain the company's Nasdaq listing.
  • A higher stock price may attract institutional investors and improve trading liquidity.
  • The reverse stock split will not change the percentage ownership of existing stockholders (except for fractional share adjustments).
  • The company will pay cash for fractional shares, avoiding the need for stockholders to deal with odd lots.

Negatives

  • The reverse stock split may not result in a permanent increase in the stock price.
  • The total market capitalization of the company may decrease after the reverse stock split.
  • Some investors may view a reverse stock split negatively, which could lead to a decrease in the stock price.
  • The reduction in outstanding shares could reduce trading liquidity.
  • The relative increase in authorized but unissued shares could have a potential anti-takeover effect.

Risks

  • The reverse stock split may not increase the stock price as intended.
  • The market price of the stock could decline after the reverse stock split.
  • The reverse stock split could result in some stockholders owning odd lots of shares.
  • The increased number of authorized but unissued shares could dilute existing stockholders' ownership if issued in the future.
  • There is no guarantee that the reverse stock split will attract institutional investors or improve trading liquidity.

Future Outlook

The company intends to regain compliance with Nasdaq listing requirements through the proposed reverse stock split. The Board will determine the exact ratio and timing of the split, and may choose not to implement it. The company may use the increased number of authorized but unissued shares for future financings or other issuances.

Management Comments

  • Our Board believes that the proposed reverse stock split is a potentially effective means for us to maintain compliance with the Nasdaq listing rules.
  • The Board may determine in its discretion not to effect any reverse stock split and not to file the Reverse Split Amendment.
  • The Boards determination as to whether and when to effect a reverse stock split will be based on a number of factors, including the closing bid price for our common stock, prevailing market conditions, existing and expected trading prices for our common stock, actual or forecasted results of operations, and the likely effect of such results on the market price of our common stock.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low stock prices. This action is often taken to regain compliance with listing requirements and potentially attract institutional investors. The success of such splits varies, and the market reaction can be unpredictable.

Comparison to Industry Standards

  • Many companies facing similar delisting threats have implemented reverse stock splits, with varying degrees of success.
  • For example, companies like Cassava Sciences (SAVA) and Ocugen (OCGN) have undergone reverse stock splits to maintain Nasdaq listing.
  • The effectiveness of a reverse stock split depends on various factors, including the company's underlying financial health and market sentiment.
  • Some companies have seen a temporary increase in stock price after a reverse split, while others have experienced further declines.
  • The specific ratio chosen for the reverse stock split is also a critical factor, with higher ratios potentially leading to greater price increases but also greater volatility.

Stakeholder Impact

  • Shareholders will be affected by the reverse stock split, potentially seeing a change in the number of shares they own and the value of their investment.
  • Employees may be affected by changes in the stock price and the value of their stock options.
  • The company's ability to raise capital and maintain its Nasdaq listing could impact its long-term viability and relationships with customers and suppliers.

Next Steps

  • Stockholders will vote on the reverse stock split proposal at the special meeting on December 23, 2024.
  • The Board will determine the exact ratio of the reverse stock split if approved by stockholders.
  • The company will file the Reverse Split Amendment with the Secretary of State of Delaware if the Board decides to proceed.
  • The company will monitor its stock price to ensure compliance with Nasdaq listing requirements.

Key Dates

DateDescription
May 26, 2010Date of filing of the original Certificate of Incorporation.
November 27, 2024Record date for determining stockholders eligible to vote at the special meeting.
December 12, 2024Date proxy materials are first being sent to stockholders.
December 23, 2024Date of the 2024 Special Meeting of Stockholders.
December 27, 2024Deadline for submitting proposals for inclusion in the 2025 proxy materials.
February 6, 2025Earliest date for submitting stockholder notice of a nomination or proposal for the 2025 annual meeting.
March 8, 2025Latest date for submitting stockholder notice of a nomination or proposal for the 2025 annual meeting.
April 7, 2025Deadline for stockholders to provide written notice for director nominees under universal proxy rules.
April 14, 2025Compliance date to regain compliance with Nasdaq's minimum bid price requirement.

Keywords

reverse stock split, Nasdaq, minimum bid price, delisting, stock price, common stock, stockholders, proxy statement, compliance, OPTN

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.